{"id":"https://openalex.org/W2010449588","doi":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","title":"Effect of 4\u2010Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers","display_name":"Effect of 4\u2010Aminopyridine on Action Potential Parameters in Isolated Dog Purkinje Fibers","publication_year":2009,"publication_date":"2009-12-15","ids":{"openalex":"https://openalex.org/W2010449588","doi":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","mag":"2010449588","pmid":"https://pubmed.ncbi.nlm.nih.gov/20428229","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2855834"},"language":"en","primary_location":{"id":"doi:10.1111/j.1753-5174.2009.00027.x","doi":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1753-5174.2009.00027.x","source":{"id":"https://openalex.org/S110110754","display_name":"Archives of Drug Information","issn_l":"1753-5174","issn":["1753-5174"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Drug Information","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1753-5174.2009.00027.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"George Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George Thomas","raw_affiliation_strings":["Department of Safety Pharmacology, Alcon Research, Ltd., Fort Worth, TX, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Safety Pharmacology, Alcon Research, Ltd., Fort Worth, TX, USA;","institution_ids":["https://openalex.org/I4210086271"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Klatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163572","display_name":"Elixir Medical (United States)","ror":"https://ror.org/05hgx8v86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163572"]},{"id":"https://openalex.org/I4405269151","display_name":"Fujirebio US (United States)","ror":"https://ror.org/0384ynf57","country_code":"US","type":"company","lineage":["https://openalex.org/I4405269151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Klatt","raw_affiliation_strings":["Calvert Laboratories, Inc., Olyphant, PA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Calvert Laboratories, Inc., Olyphant, PA, USA;","institution_ids":["https://openalex.org/I4210163572","https://openalex.org/I4405269151"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029171966","display_name":"Andrew R. Blight","orcid":"https://orcid.org/0009-0006-8616-6264","observed_orcids":["https://orcid.org/0009-0006-8616-6264"]},"institutions":[{"id":"https://openalex.org/I28806726","display_name":"Acorda Therapeutics (United States)","ror":"https://ror.org/01788sq40","country_code":"US","type":"company","lineage":["https://openalex.org/I28806726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Blight","raw_affiliation_strings":["Acorda Therapeutics, Inc., Hawthorne, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acorda Therapeutics, Inc., Hawthorne, NY, USA","institution_ids":["https://openalex.org/I28806726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210086271"],"apc_list":null,"apc_paid":null,"fwci":1.0787,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.80098862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"3","issue":"1","first_page":"19","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11217","display_name":"Cardiac Arrhythmias and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4-aminopyridine","display_name":"4-aminopyridine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fampridine","display_name":"fampridine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/purkinje-fibers","display_name":"Purkinje fibers","score":0.9010000228881836},{"id":"https://openalex.org/keywords/action-potential-duration","display_name":"action potential duration","score":0.9079999923706055},{"id":"https://openalex.org/keywords/potassium-channel-blockers","display_name":"potassium channel blockers","score":0.7149999737739563},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9210000038146973},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cardiac-electrophysiology","display_name":"cardiac electrophysiology","score":0.6449999809265137},{"id":"https://openalex.org/keywords/action-potential-upstroke","display_name":"action potential upstroke","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2777463368","wikidata":"https://www.wikidata.org/wiki/Q2014587","display_name":"Purkinje fibers","level":3,"score":0.8687374591827393},{"id":"https://openalex.org/C2780922449","wikidata":"https://www.wikidata.org/wiki/Q372539","display_name":"4-Aminopyridine","level":3,"score":0.7942571640014648},{"id":"https://openalex.org/C146403970","wikidata":"https://www.wikidata.org/wiki/Q205729","display_name":"Repolarization","level":3,"score":0.6930681467056274},{"id":"https://openalex.org/C2780486423","wikidata":"https://www.wikidata.org/wiki/Q1625433","display_name":"Torsades de pointes","level":3,"score":0.687775194644928},{"id":"https://openalex.org/C4141045","wikidata":"https://www.wikidata.org/wiki/Q83183","display_name":"Depolarization","level":2,"score":0.6067690253257751},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.5738521814346313},{"id":"https://openalex.org/C181911157","wikidata":"https://www.wikidata.org/wiki/Q389844","display_name":"Membrane potential","level":2,"score":0.5285802483558655},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4954127073287964},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4733719229698181},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46556806564331055},{"id":"https://openalex.org/C93872552","wikidata":"https://www.wikidata.org/wiki/Q4690722","display_name":"Afterhyperpolarization","level":3,"score":0.41865071654319763},{"id":"https://openalex.org/C185263204","wikidata":"https://www.wikidata.org/wiki/Q1154774","display_name":"Electrophysiology","level":2,"score":0.415446937084198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3501325249671936},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.3111267387866974},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07886570692062378}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1753-5174.2009.00027.x","doi":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1753-5174.2009.00027.x","source":{"id":"https://openalex.org/S110110754","display_name":"Archives of Drug Information","issn_l":"1753-5174","issn":["1753-5174"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Drug Information","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2855834","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2855834","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arch Drug Inf","raw_type":"Text"},{"id":"pmid:20428229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20428229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of drug information","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1753-5174.2009.00027.x","doi":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1753-5174.2009.00027.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1753-5174.2009.00027.x","source":{"id":"https://openalex.org/S110110754","display_name":"Archives of Drug Information","issn_l":"1753-5174","issn":["1753-5174"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Drug Information","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315053","display_name":"Acorda Therapeutics","ror":"https://ror.org/01788sq40"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2010449588.pdf","grobid_xml":"https://content.openalex.org/works/W2010449588.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1557401510","https://openalex.org/W1830737945","https://openalex.org/W1840457973","https://openalex.org/W1968098810","https://openalex.org/W1969198078","https://openalex.org/W1984175906","https://openalex.org/W1996607415","https://openalex.org/W1997582961","https://openalex.org/W2021438486","https://openalex.org/W2025504409","https://openalex.org/W2031082174","https://openalex.org/W2033993037","https://openalex.org/W2040560309","https://openalex.org/W2043579592","https://openalex.org/W2044491512","https://openalex.org/W2048960037","https://openalex.org/W2055019645","https://openalex.org/W2055127611","https://openalex.org/W2062521762","https://openalex.org/W2063387324","https://openalex.org/W2067783737","https://openalex.org/W2085048839","https://openalex.org/W2092086698","https://openalex.org/W2093024696","https://openalex.org/W2097169806","https://openalex.org/W2113927644","https://openalex.org/W2115053151","https://openalex.org/W2129173665","https://openalex.org/W2134467864","https://openalex.org/W2137067311","https://openalex.org/W2144381908","https://openalex.org/W2157620332","https://openalex.org/W2163863644","https://openalex.org/W2272023715","https://openalex.org/W2468747016","https://openalex.org/W4292004352"],"related_works":["https://openalex.org/W7096679200","https://openalex.org/W2063387324","https://openalex.org/W2402896180","https://openalex.org/W3146945047","https://openalex.org/W7101095706","https://openalex.org/W2436983748","https://openalex.org/W2063095645","https://openalex.org/W202411505","https://openalex.org/W1988256405","https://openalex.org/W1979954740"],"abstract_inverted_index":{"INTRODUCTION:":[0],"4-Aminopyridine":[1],"(fampridine),":[2],"a":[3,32],"potassium":[4],"channel":[5],"blocker,":[6],"has":[7],"demonstrated":[8],"efficacy":[9],"in":[10,18,24,89,106],"improving":[11],"lower":[12],"extremity":[13],"strength":[14],"and":[15,40,59,80,95,117,156,168,176],"walking":[16],"speed":[17],"patients":[19],"with":[20,123,136],"multiple":[21],"sclerosis.":[22],"Since":[23],"vitro":[25],"electrophysiologic":[26,52],"studies":[27],"are":[28],"recommended":[29],"for":[30,172],"evaluating":[31],"drug's":[33],"potential":[34,78],"to":[35,138,195],"prolong":[36],"the":[37,51,70,86,101,107,125,129,144],"QT":[38,196],"interval":[39,197],"induce":[41],"such":[42],"cardiac":[43],"arrhythmias":[44],"as":[45],"Torsades":[46],"de":[47],"Pointes,":[48],"we":[49],"examined":[50],"effects":[53],"of":[54,76,83,85,100,109,188],"4-aminopyridine":[55],"(0.5,":[56],"5.0,":[57],"50,":[58],"500":[60],"microM)":[61],"on":[62],"isolated":[63],"canine":[64],"Purkinje":[65,90],"fibers.":[66],"METHODS:":[67],"Microelectrodes":[68],"monitored":[69],"resting":[71],"membrane":[72],"potential,":[73],"overshoot,":[74],"amplitude":[75],"action":[77],"(AP),":[79],"maximal":[81],"rate":[82,181],"depolarization":[84],"AP":[87,112],"upstroke":[88],"fibers":[91],"stimulated":[92],"at":[93,114,128],"0.5":[94],"1.0":[96],"Hz.":[97],"RESULTS:":[98],"None":[99],"above":[102],"variables":[103],"were":[104,161],"altered":[105],"presence":[108],"4-aminopyridine.":[110],"The":[111,153],"duration":[113],"30%,":[115,174],"50%,":[116,175],"90%":[118,177],"repolarization":[119],"was":[120,151,183],"also":[121],"monitored,":[122],"only":[124],"500-microM":[126],"concentration":[127],"1.0-Hz":[130],"frequency":[131],"significantly":[132],"increasing":[133],"these":[134],"values":[135],"respect":[137],"baseline":[139],"(P":[140],"<":[141],"0.05).":[142],"However,":[143],"small":[145],"sample":[146],"size":[147],"(N":[148],"=":[149],"4)":[150],"small.":[152],"proportional":[154],"increases,":[155],"their":[157],"95%":[158],"confidence":[159],"intervals,":[160],"90.8%":[162],"(-36.4%,":[163],"218.0%),":[164],"25.8%":[165],"(11.9%,":[166],"39.7%),":[167],"22.0%":[169],"(14.9%,":[170],"29.1%)":[171],"APD":[173],"repolarization,":[178],"respectively.":[179],"Reverse":[180],"dependence":[182],"not":[184],"observed,":[185],"suggesting":[186],"inhibition":[187],"ion":[189],"channels":[190],"other":[191],"than":[192],"those":[193],"contributing":[194],"prolongation.":[198]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}